UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2502-2512

2005

Volltextzugriff (PDF)

A multimarker model to predict outcome in tamoxifen-treated breast cancer patients

Clinical cancer research, 2006-02, Vol.12 (4), p.1175-1183

2006

Volltextzugriff (PDF)

Frequency Characterization of Blood Glucose Dynamics

Annals of biomedical engineering, 2003-01, Vol.31 (1), p.91-97

2003

Volltextzugriff (PDF)

Prognostic marker profile to assess risk in stage I–III hormone receptor‐positive breast cancer patients

International journal of cancer, 2009-02, Vol.124 (4), p.896-904

2009

Volltextzugriff (PDF)

63: Développement du test pronostic Insight DxTM pour la prédiction de récidive du cancer du sein et pour le choix d’un traitement adjuvant personnalisé

Bulletin du cancer, 2010-03, Vol.97 (1), p.S56-S57

2010

Volltextzugriff (PDF)

Abstract P4-11-18: FOXA1 and PR predict ipsilateral event risk and identify a group with strong radiation response in ductal carcinoma in situ (DCIS)

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P4-P4-11-18

2015

Volltextzugriff (PDF)

Abstract P4-11-17: Validation of a multi-marker test that predicts recurrence in patients diagnosed with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery (BCS)

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P4-P4-11-17

2015

Volltextzugriff (PDF)

FOXA1 and PR predict ipsilateral event risk and identify a group with strong radiation response in ductal carcinoma in situ (DCIS)

Cancer research (Chicago, Ill.), 2015, Vol.75 (9)

2015

Volltextzugriff (PDF)

Validation of a multi-marker test that predicts recurrence in patients diagnosed with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery (BCS)

Cancer research (Chicago, Ill.), 2015, Vol.75 (9)

2015

Volltextzugriff (PDF)

Frequency characterization of blood glucose dynamics

Annals of biomedical engineering, 2003-01, Vol.31 (1), p.91

2003

Volltextzugriff (PDF)

Benchmark data from the literature for evaluation of new glucose sensing technologies

Diabetes technology & therapeutics, 2001, Vol.3 (3), p.409-418

2001

Volltextzugriff (PDF)

Investigation of the predictability of blood glucose dynamics, based solely on preceding blood glucose measurements and implications for the treatment of diabetes mellitus

Bremer, Troy M

1999

Volltextzugriff (PDF)

Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy

Clinical cancer research, 2020-08, Vol.26 (15), p.4054-4063

2020

Volltextzugriff (PDF)

A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy

International journal of radiation oncology, biology, physics, 2023-01, Vol.115 (1), p.93-102

2023

Volltextzugriff (PDF)

Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors

Modern pathology, 2023-11, Vol.36 (11), p.100318-100318, Article 100318

2023

Volltextzugriff (PDF)

The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study

Annals of surgical oncology, 2024-09, Vol.31 (9), p.5919-5928

2024

Volltextzugriff (PDF)

ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study

Annals of surgical oncology, 2024-09, Vol.31 (9), p.5959-5960

2024

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies

A multimarker model to predict outcome in tamoxifen-treated breast cancer patients

Frequency Characterization of Blood Glucose Dynamics

Prognostic marker profile to assess risk in stage I–III hormone receptor‐positive breast cancer patients

63: Développement du test pronostic Insight DxTM pour la prédiction de récidive du cancer du sein et pour le choix d’un traitement adjuvant personnalisé

Abstract P4-11-18: FOXA1 and PR predict ipsilateral event risk and identify a group with strong radiation response in ductal carcinoma in situ (DCIS)

Abstract P4-11-17: Validation of a multi-marker test that predicts recurrence in patients diagnosed with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery (BCS)

FOXA1 and PR predict ipsilateral event risk and identify a group with strong radiation response in ductal carcinoma in situ (DCIS)

Validation of a multi-marker test that predicts recurrence in patients diagnosed with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery (BCS)

Frequency characterization of blood glucose dynamics

Benchmark data from the literature for evaluation of new glucose sensing technologies

Investigation of the predictability of blood glucose dynamics, based solely on preceding blood glucose measurements and implications for the treatment of diabetes mellitus

Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy

A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy

Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors

The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study

ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study

Suchergebnisse filtern